Healthcare industry

Press release - 01/11/2008

Boris Mizaikoff and Christine Kranz – on the way to systems analytics

The two chemists Boris Mizaikoff and Christine Kranz have a great deal in common they are married to each other they have children together and they work at the same university on projects that combine technologies and methods to create multifunctional analytical platforms at the Department of Analytical and Bioanalytical Chemistry at Ulm University.

Innovative Therapies - 20/08/2020

Labor Dr. Merk is fully committed to viral therapies

Labor Dr. Merk & Kollegen is reorienting its business towards viral therapeutics. With this change of strategy, the company, which has decades of expertise in virology, wants to position itself in a timely fashion in the growing new market for advanced therapy medicinal products (ATMP). In gene and virotherapies (oncolytic viruses), tumour vaccines and CAR-T cell therapies, viruses are essential as vectors, killers of tumour cells or…

Press release - 08/01/2009

ILM – Optical analytics

In collaboration with the company Labor Dr. Merk & Kollegen GmbH and the Institute of Virology at the University of Ulm, the ILM is developing an innovative detection system for the early diagnosis of influenza virus infections in pharyngeal secretions.

Pharmaceutical research and life sciences profit from unique biosensor technology - 18/09/2015

Biametrics GmbH concludes financing round with 3.1 Million Euro

Biametrics GmbH today announced the completion of their most recent financing round with €3.1 Million. Partners of the A Series Investment were LBBW Venture GmbH, MBG Mittelständische Beteiligungsgesellschaft BW, and KfW Bankengruppe. Together with seed investors HTGF and Seedfonds BW, they are aiming to accelerate the expansion of Biametrics’ bioanalytical business activities to an international level. The fresh capital will facilitate the…

Article - 19/11/2012

Biopharm GmbH: growth factors for use in regenerative medicine

With more than 26 years’ experience in the field of orthopaedics, dermatology and personalised medicine, the Heidelberg-based biotechnology company Biopharm GmbH is firmly established in the regenerative medicine market. Based on its proprietary growth factor technology platform, Biopharm develops innovative methods for the treatment of bone and cartilage damage and improvement of the wound healing process.

Article - 04/04/2016

An intelligent system for the storage and controlled release of pharmaceutical substances

A sophisticated reservoir that sits under the skin and dispenses precise quantities of drugs locally and at a particular point in time now exists. A junior research group from the University of Freiburg’s BrainLinks-BrainTools excellence cluster led by Dr. Maria Asplund and her doctoral student Christian Böhler from the Department of Microsystems Engineering (IMTEK) has developed a small storage system made of organic-inorganic hybrid material…

GATC, one of the leading sequencing provider will be a part of the Eurofins Group as of July 2017 to create the leading company in the worldwide sequencing market.

Article - 16/05/2011

New analysis tools involving molecularly imprinted polymers

The demand for made-to-measure analytical methods is increasing as interest in the biological production of materials and pharmaceuticals increases. It is extremely important economically for bioindustry to know the production time and quantity of products that result from specific fermentation conditions. Inspired by natural molecular processes, researchers from Tübingen and Stuttgart are working on new, label-free analytical methods that make…

Article - 14/02/2011

Marilena Manea: targeted chemotherapy to treat cancer

After cardiovascular diseases cancer is the second leading cause of death in Germany. At the University of Konstanz Dr. Marilena Manea and her research group are working on the development of bioconjugates for targeted cancer chemotherapy. The researchers goal is to improve the efficiency and tolerability of the chemotherapeutic drugs that are already being used in hospitals.

Article - 09/08/2010

Quick and early detection of rare diseases

Lysosomal storage diseases LSD are a group of around 50 rare inherited metabolic disorders. Only 12 LSDs have been described biochemically and microbiologically. Prof. Dr. Michael Przybylski from the Steinbeis Transfer Centre for Biopolymer Analysis and Proteomics at the University of Constance now hopes to change this situation. In a project carried out in cooperation with the biotech company Genzyme CEE Konstanz and the University of Timisoara…

Biametrics Marken and Rechte GmbH has developed new analytical devices based on reflectometric interference spectroscopy thus adopting the trend of label-free detection methods. This is because labelling tends to interfere with the natural activity of the biomolecules under investigation.

SICOS BW GmbH - 18/06/2020

High-performance computing and data analytics to combat coronavirus

In an epidemic, data exchange and the use of innovative technologies are essential to be able to act effectively and quickly against the infection. High-performance computers and data analytics make a valuable contribution to this. SICOS BW is a promising solution centre that bridges the gap from numerical simulation, big data and AI to companies in the medical technology sector.

Article - 04/10/2010

ANASYN Ozan Gökay – research laboratory for complex tasks

Ozan Gökay, chemical engineer and chemist, has been thinking about setting up his own company for many years. Now he is about to turn his plans into reality and his company ANASYN will start operating in November 2010. The company will focus on analytics, syntheses and biotechnology.

Dossier - 03/06/2013

Food analytics – applied consumer protection

Consumers – in other words, all of us – rightly expect to be supplied with healthy, high-quality and safe foods. However, over the past few years, food scandals have frequently hit the headlines. They are brought to light in laboratories that have a huge arsenal of methods and procedures to analyse food. Although the media would have us believe otherwise, the vast majority of foods are safe and very rarely hazardous to human health. This is in…

Article - 05/11/2012

Walter Vetter: analytics that guarantees consumer safety

How do consumers know whether the food item they have purchased actually is the product with the desired properties or whether the packaging promises more than the product actually delivers? This is not a judgement that can be made based on the product’s appearance or taste. Only analytical methods can get to the bottom of the molecules inside the food item. Prof. Dr. Walter Vetter at the Institute of Food Chemistry at the University of Hohenheim…

Article - 24/01/2011

Protzek GmbH: On site drug testing and analytics

How do you find out if someone is driving under the influence of alcohol or drugs? Up until now the police had to visually inspect and assess test strips in order to convict a drunken or doped driver. Lörrach-based Protzek Gesellschaft für Biomedizinische Technik mbH have improved this situation with the development of a mobile system that uses objective criteria to quantitatively analyse drugs and medications on site.

Article - 07/06/2010

Biametrics – specialist in label-free bioanalysis

Biametrics is a spin-off from the University of Tübingen that focuses on the commercialisation of innovative developments in the field of label-free bioanalyses. The companys platform detects interactions between biomolecules using reflectometric interference spectroscopy RIfS and can be integrated into small mobile analytical devices.

Press release - 15/11/2011

PANATecs GmbH will move into new laboratories in Heilbronn in 2012

In Summer 2012, PANATecs will move its headquarters to Heilbronn, where the firm will have modern and purpose-built laboratories in the Wohlgelegen Research Park.

Baden-Württemberg is currently home to 188 biotechnology companies. In addition to dedicated biotechnology companies, this also includes bioinformatics, diagnostics and analytics companies that use modern biotechnology methods or focus on biotechnological production.

Press release - 12/12/2017

BRAIN AG and Mannheim University develop 3D skin models for health care and cosmetics

Research collaboration in project M2Aind for new real-time and high-resolution screening technologies of 3D skin spheroids. Mannheim University of Applied Sciences builds on expertise in 3D cell culture and advanced live cell imaging. BRAIN contributes unique skin reporter cells, screening compound libraries and market knowledge. Review article in Journal of Cellular Biotechnology.

In the not-too-distant future, food analysts hope they will be able do more than just detect mycotoxin traces and determine the concentration of individual nutrients such as vitamin C. Their ambition is in fact much broader: “We would like to understand the nutritional and physiological effect of food,” said Prof. Sabine Kulling from the Max Rubner Institute in Karlsruhe. As with other life sciences areas, metabolomics is seen as a key technology…

Press release - 26/09/2011

Unraveling the properties of plant substances

Researchers from the Institute of Analytical Chemistry at the Mannheim University of Applied Sciences are focusing on sensors in their effort to increase the yields of bioreactors and reduce the number of animals used for toxicity testing of pharmaceuticals. In addition, the chemists from Mannheim are aiming to investigate the activity of plant substances in the Bioactive Plant Foods Network, a transnational network for the promotion of bioactive…

Article - 13/12/2016

Smart sensor technology from Ulm can do more than just breath analysis

Detecting disease-specific molecules in human breath is technically feasible, but time-consuming and rather costly. "µbreath" could soon change this. The breath gas analysis device has all the necessary requirements for commercial success in the healthcare sector: it is compact, accurate, highly sensitive and fast. The chemist who developed µbreath, Prof. Boris Mizaikoff from Ulm University, and his partners are hoping to start…